Cell therapy is an ever evolving industry in which clients creating new biological tools and technologies are being met with a number of complicated legal and regulatory challenges. From collaboration agreements to joint ventures to litigation strategies, we help clients navigate those challenges and even create opportunities.

Lorem ipsum dolor sit amet, pro dicunt omnesque atomorum et, in quo bonorum tacimates. Id ius illud novum. Ius graeci nostrum id. Brute meliore ad vis, vel omnium perfecto est. Lorem ipsum dolor sit amet, pro dicunt omnesque atomorum et, in quo bonorum tacimates. Id ius illud novum. Ius graeci nostrum id. Brute meliore ad vis, vel omnium perfecto. Lorem ipsum dolor sit amet, pro dicunt omnesque atomorum et, in quo bonorum tacimates. Id ius illud novum. Lorem ipsum dolor sit amet, pro dicunt omnesque atomorum.

Key contact

Contact

Experience

Latest articles

What others say

“The team was equally willing to embrace and incorporate new concepts, and their general approach was to always look to provide solutions or alternative ways to achieve the right outcomes.”

Chambers and Partners 2020

“It’s a very impressive firm. They deliver excellent service and they’re focused on client delivery.”

Chambers and Partners 2020

“It is a high-quality team of practical thinkers who know what is needed in business.”

Chambers and Partners 2020

“Noted for particular strength in IP litigation and the licensing of telecoms SEPs.”

Chambers and Partners 2020

“They really do invest in the relationship”

Chambers and Partners 2020

Recent rankings and awards

Life Sciences - Top tier
Chambers and Partners UK 2017

Pharmaceuticals and Biotechnology - Top tier
Legal 500 2017

Life Sciences Chambers and Partners 2017
Chambers and Partners Europe 2017